P-TEFb | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,093 results for “P-TEFb”

Trials

View all 1483 →

P-REMI trial (P-REMI trial)

120 participants

CALV-P study (CALV-P study)

30 participants

Linked color image for SSA/P (LCI for SSA/P)

51 participants

Drugs

View all 979 →

small molecule inhibitors of Tat-TAR-P-TEFb (HIV infection)

P-1736

P-16

Organizations

View all 79 →

DR APOORVA A P

India

DENVER NEPHROLOGISTS P C

United States

Hugh P McElwee Md

United States

News

View all 3552 →

New P-TEFb–BHLHE40–Tim8/Tim13 Axis Reveals HIF-Independent Hypoxic Gene Regulation in Treatment-Resistant Tumors

Quanterix Launches Novel P-Tau 205 and P-Tau 212 Assays to Advance Alzheimer's Research

Quanterix Launches First-to-Market p-Tau 205 and p-Tau 212 Assays for Alzheimer's Disease Research

Page 1 of 610